BNO 5.26% 20.0¢ bionomics limited

Ann: Further Analysis of Phase 2 PTSD Trial Results Presentation, page-12

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 590 Posts.
    lightbulb Created with Sketch. 4
    also the shenanigans last thursday where 5 million shares changed hands at $0.12 suggests not everyone found out at the same time.

    the announcement today that was "actually where the drug is in the blood it can treat ptsd symptoms" should have been released into a TH.

    also at the end of last year when they said no additional work is being done on 210 apart from agitation - todays announcement is at odds with that. At the very least they have done work on drug delivery.

    I agree *in my opinion* I feel that we've been misled, diluted and made poorer.

    there's still enough for me to hold. but at best today feels bitter sweet.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.